Whitehawk Therapeutics, Inc.(WHWK:US)
Market Cap$136.4M
Key Metrics
Price$2.89
Revenue (TTM)$0
Holders Revenue (TTM)-
Gross Profit (TTM)$0
Earnings (TTM)-$115.81M
EBITDA (TTM)-$116.94M
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$34.79M
Total Assets$127.23M
Net Assets$116.18M
Total Debt$0
Key Metrics
Price$2.89
Revenue (TTM)$0
Holders Revenue (TTM)-
Gross Profit (TTM)$0
Earnings (TTM)-$115.81M
EBITDA (TTM)-$116.94M
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$34.79M
Total Assets$127.23M
Net Assets$116.18M
Total Debt$0
Financials
| Name | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 | - | - | - | - | - | - | - |
Cost of Revenue | $0 | $0 | $0 | $0 | $760K | $790K | $804K | $778K | $652K | $927K | $697K |
Gross Profit | $0 | $0 | $0 | $0 | - | - | - | - | - | - | - |
| $23.52M | $24.89M | $19.55M | $54.75M | - | - | - | - | - | - | - | |
| Research and Development | $17.23M | $19.02M | $14.35M | $48.81M | - | - | - | - | - | - | - |
| Selling, General, and Administrative | $6.29M | $5.87M | $5.2M | $5.94M | - | - | - | - | - | - | - |
| Other Operating Expenses | - | - | - | - | - | - | - | - | - | - | - |
Operating Income | -$23.52M | -$24.89M | -$19.55M | -$54.75M | - | - | - | - | - | - | - |
| $1.33M | $1.64M | $1.8M | $2.13M | $791K | $676K | $906K | $1.06M | $1.28M | $1.5M | $1.61M | |
| Non-Operating Interest Income | $1.33M | $1.61M | $1.85M | $1.98M | $791K | $676K | $906K | $1.06M | $1.28M | $1.5M | $1.61M |
| Non-Operating Interest Expense | - | $0 | $0 | $0 | - | - | - | - | - | - | - |
| Other Income/Expense | - | $25K | -$50K | $155K | - | - | - | - | - | - | - |
Income Before Tax | -$22.19M | -$23.25M | -$17.75M | -$52.62M | - | - | - | - | - | - | - |
Income Tax | $0 | - | - | - | - | - | - | - | - | - | - |
Net Income | -$22.19M | -$23.25M | -$17.75M | -$52.62M | - | - | - | - | - | - | - |
Minority Interests | - | - | - | - | - | - | - | - | - | - | - |
Preferred Stock Dividends | - | - | - | - | - | - | - | - | - | - | - |
Net Income to Common | -$22.19M | -$23.25M | -$17.75M | -$52.62M | - | - | - | - | - | - | - |
Shares Outstanding (Basic) | 69.24M | 69.21M | 69.2M | 69.08M | 39.64M | 27.09M | 27.04M | 27.01M | 26.98M | - | - |
Shares Outstanding (Diluted) | 69.24M | 69.21M | 69.2M | 69.08M | 39.93M | 27.09M | 27.04M | 27.01M | 26.98M | - | - |
EPS (Basic) | -$0.32 | -$0.34 | -$0.26 | -$0.76 | $1.84 | -$0.67 | -$0.46 | -$0.54 | -$0.68 | - | - |
EPS (Diluted) | -$0.32 | -$0.34 | -$0.26 | -$0.76 | $1.83 | -$0.67 | -$0.46 | -$0.54 | -$0.68 | - | - |
EBIT | -$23.52M | -$23.25M | -$17.75M | -$52.62M | - | - | - | - | - | - | - |
EBITDA | -$23.52M | -$23.26M | -$17.56M | -$52.6M | - | - | - | - | - | - | - |